Bülent Karabulut

1.6k total citations
109 papers, 1.2k citations indexed

About

Bülent Karabulut is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Bülent Karabulut has authored 109 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Oncology, 31 papers in Molecular Biology and 29 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Bülent Karabulut's work include Colorectal Cancer Treatments and Studies (26 papers), Cancer Treatment and Pharmacology (17 papers) and Colorectal Cancer Surgical Treatments (11 papers). Bülent Karabulut is often cited by papers focused on Colorectal Cancer Treatments and Studies (26 papers), Cancer Treatment and Pharmacology (17 papers) and Colorectal Cancer Surgical Treatments (11 papers). Bülent Karabulut collaborates with scholars based in Türkiye, Switzerland and United States. Bülent Karabulut's co-authors include Rüçhan Uslu, Canfeza Sezgin, Erdem Göker, Burçak Karaca, Harika Atmaca, Selim Uzunoğlu, Ulus Ali Şanlı, Ender Terzıoğlu, Aslı Kısım and Yüksel Küçükzeybek and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Bülent Karabulut

100 papers receiving 1.2k citations

Peers

Bülent Karabulut
Bülent Karabulut
Citations per year, relative to Bülent Karabulut Bülent Karabulut (= 1×) peers Raffaele Ardito

Countries citing papers authored by Bülent Karabulut

Since Specialization
Citations

This map shows the geographic impact of Bülent Karabulut's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bülent Karabulut with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bülent Karabulut more than expected).

Fields of papers citing papers by Bülent Karabulut

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bülent Karabulut. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bülent Karabulut. The network helps show where Bülent Karabulut may publish in the future.

Co-authorship network of co-authors of Bülent Karabulut

This figure shows the co-authorship network connecting the top 25 collaborators of Bülent Karabulut. A scholar is included among the top collaborators of Bülent Karabulut based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bülent Karabulut. Bülent Karabulut is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Uras, Cihan, Mahmut Çerkez Ergören, Cemil Bilir, et al.. (2025). P044: Examining the Correlation and Concordance Between Ki-67 Expression and Oncotype DX Recurrence Score: Findings from a Multicenter Study in Turkey. The Breast. 80. 103928–103928.
3.
Αγιαννιτόπουλος, Κωνσταντίνος, Georgios Tsaousis, Mustafa Özdoğan, et al.. (2023). Genetic testing in patients with pancreatic cancer to reveal pathogenic variants in cancer susceptibility genes.. Journal of Clinical Oncology. 41(16_suppl). e16276–e16276. 1 indexed citations
4.
Özet, Ahmet, Faysal Dane, Nuri Faruk Aykan, et al.. (2022). Safety and efficacy of trifluridine/tipiracil in previously treated metastatic colorectal cancer: PRECONNECT Turkey. Future Oncology. 18(29). 3267–3276. 2 indexed citations
5.
Oruç, Nevin, Deniz Yalman, Denız Nart, et al.. (2020). Ege Üniversitesi hastanesi veri tabanındaki pankreas kanserlerinin epidemiyolojik ve genel sağkalım özellikleri. Ege Tıp Dergisi. 25–32. 1 indexed citations
6.
Karabulut, Bülent, et al.. (2020). Flavones (Apigenin, Luteolin, Chrysin) and Their Importance for Health. DergiPark (Istanbul University). 3 indexed citations
7.
Çakar, Burcu, Atike Pınar Erdoğan, Raika Durusoy, et al.. (2015). The Role of Body Mass Index in Triple Negative Breast Cancer. Oncology Research and Treatment. 38(10). 518–522. 12 indexed citations
8.
Fadıloğlu, Çiçek, et al.. (2014). Kanser hastasının palyatif bakımında vaka yönetimine dayalı multidispliner bakım protein. Ağrı - The Journal of The Turkish Society of Algology. 26(2). 47–56. 1 indexed citations
9.
Varol, Umut, Ahmet Dirican, İbrahim Yıldız, et al.. (2014). First-Line Mono-Chemotherapy in Frail Elderly Patients with Metastatic Colorectal Cancer. Asian Pacific Journal of Cancer Prevention. 15(7). 3157–3161. 2 indexed citations
10.
Kurt, Ender, Erdem Çubukçu, Bülent Karabulut, et al.. (2013). A multi-institutional evaluation of carboplatin plus docetaxel regimen in elderly patients with advanced gastric cancer.. PubMed. 18(1). 147–53. 3 indexed citations
11.
Kısım, Aslı, Harika Atmaca, Burcu Çakar, et al.. (2012). Pretreatment with AT-101 enhances tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis of breast cancer cells by inducing death receptors 4 and 5 protein levels. Journal of Cancer Research and Clinical Oncology. 138(7). 1155–1163. 21 indexed citations
12.
Varol, Umut, Burçak Karaca, Burcu Çakar, et al.. (2012). Comparing Time to Disease Progression of Irinotecan and Oxaliplatin-based Chemotherapies in Colorectal Cancer Patients With Liver Only Metastasis. American Journal of Clinical Oncology. 36(4). 388–391. 5 indexed citations
13.
Uzunoğlu, Selim, Burçak Karaca, Harika Atmaca, et al.. (2011). Targeting Bcl-2 Protein to Enhance Chemosensitivity of Hormone Refractory Prostate Cancer Cell Line, DU-145 by a Synergistic Combination of Docetaxel and Gossypol. Turkiye Klinikleri Journal of Medical Sciences. 31(4). 859–866. 1 indexed citations
14.
Küçükzeybek, Yüksel, Burçak Karaca, Bülent Karabulut, et al.. (2009). Trastuzumab Induced Maculopapular Skin Reactions Localized on the Left Forearm and Arm: A Case Report. Turkiye Klinikleri Tip Bilimleri Dergisi. 29(6). 1743–1746. 2 indexed citations
15.
Atmaca, Harika, Burçak Karaca, Selim Uzunoğlu, et al.. (2009). Combined gossypol and zoledronic acid treatment results in synergistic induction of cell death and regulates angiogenic molecules in ovarian cancer cells. European Cytokine Network. 20(3). 121–130. 22 indexed citations
16.
Küçükzeybek, Yüksel, Mustafa Gül, Çiğdem Erten, et al.. (2008). Enhancement of docetaxel-induced cytotoxicity and apoptosis by all-trans retinoic acid (ATRA) through downregulation of survivin (BIRC5), MCL-1 and LTbeta-R in hormone- and drug resistant prostate cancer cell line, DU-145. Journal of Experimental & Clinical Cancer Research. 27(1). 37–37. 25 indexed citations
17.
Terek, Mustafa Coşan, Bülent Karabulut, Levent Akman, et al.. (2006). Arsenic trioxide-loaded, microemulsion-enhanced cytotoxicity on MDAH 2774 ovarian carcinoma cell line. International Journal of Gynecological Cancer. 16(2). 532–537. 2 indexed citations
18.
Sezgin, Canfeza, Bülent Karabulut, Rüçhan Uslu, et al.. (2005). Gemcitabine treatment in patients with inoperable locally advanced/metastatic pancreatic cancer and prognostic factors. Scandinavian Journal of Gastroenterology. 40(12). 1486–1492. 28 indexed citations
19.
Şanlı, Ulus Ali, Rüçhan Uslu, Bülent Karabulut, et al.. (2002). Which dosing scheme is suitable for the taxanes? anin vitro model. Archives of Pharmacal Research. 25(4). 550–555. 5 indexed citations
20.
Hekimgil, Mine, et al.. (2001). Small Cell Neuroendocrine Carcinoma of the Thymus Complicated by Cushing's Syndrome. Pathology - Research and Practice. 197(2). 129–133. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026